Maryland SB987 modifies corporate income tax to fund health insurance subsidies and direct-to-consumer pharmaceutical advertising.
Maryland SB987 modifies the corporate income tax to allocate funds for health insurance subsidies and direct-to-consumer pharmaceutical advertising. The Board of Trustees of the Maryland Health Benefit Exchange will distribute income tax revenue between health insurance subsidy programs. The Comptroller will distribute remaining income tax revenue to the Maryland Health Benefit Exchange Fund. The bill also defines terms such as "covered drug" and "covered entity" and specifies the distribution of certain direct-to-consumer advertising expenses.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.